SCC
ZURAW

Spring Creek Capital’s Zura Bio Limited Warrants ZURAW Stock Holding History

Spring Creek Capital’s Portfolio ZURAW Stock Details ZURAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-150,000
Closed -$64K – 214
2022
Q1 		$64K Hold
150,000
– – ﹤0.01% 526
2021
Q4 		$69K Hold
150,000
– – ﹤0.01% 514
2021
Q3 		$90K Buy
+150,000
New +$87.5K ﹤0.01% 412

Other funds holding ZURAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Spring Creek Capital's ZURAW Position: Q2 2022 in Review

Spring Creek Capital sold out of Zura Bio Limited Warrants (ZURAW) in Q2 2022, closing a stake of 150,000 shares — an estimated $64K sold.

Spring Creek Capital first reported a position in ZURAW in Q3 2021 and held it in 3 quarters. The position peaked at $90K in Q3 2021. 25 funds tracked by Wall St. Rank hold ZURAW as of Q2 2022.

  • Spring Creek Capital reported no remaining Zura Bio Limited Warrants position as of Q2 2022 after selling out during the quarter.
  • Spring Creek Capital sold 150,000 Zura Bio Limited Warrants shares in Q2 2022, an estimated $64K.
  • Spring Creek Capital first reported a position in Zura Bio Limited Warrants in Q3 2021 and held it in 3 quarters.
  • Spring Creek Capital's Zura Bio Limited Warrants position peaked at $90K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.